drugset
drugset / Trial / NCT05537090

A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants

NCT05537090 ↗

Phase 1 Completed 16 enrolled BioVersys AG Clinical Research Units Hungary · collab
NaSequentialOpen-labelTreatment

Summary

To evaluate the effect of repeated doses of intravenous BV100 on the pharma-cokinetics of midazolam and 1-hydroxymidazolam.

Timeline

Start
2022-09-01
Primary completion
2023-07-31
Completion
2023-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule — Oral
Subject Rifabutin Small molecule — Intravenous

Indications

No indication recorded.